Hypodontia phenotype in patients with epithelial ovarian cancer

1. Cancer in Slovenia 2010. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2011. p. 37.Search in Google Scholar

2. Cancer Research UK. Statistical Information Team; 2012. Available at: http:/ www.info.cancerresearchuk.org/cancerstatsSearch in Google Scholar

3. United States cancer statistics: 1999-2008 incidence and mortality Wbbased report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2010. Available at: http://www.cdc.fov/uscsSearch in Google Scholar

4. Zhang B, Cai FF, Zhong XY. An overview of biomarkers for the ovarian cancer diagnosis. Eur J Obstet Gynecol Reprod Biol 2011; 158: 119-23.10.1016/j.ejogrb.2011.04.023Search in Google Scholar

5. Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huetter PC, Fasih N. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radio Graphics 2011; 31: 625-46.10.1148/rg.313105066Search in Google Scholar

6. Paulsen T, Kærn J, Kiærheim K, Tropé C, Tretli S. Symptoms and referral of women with epithelial ovarian tumors. Int J Gynecol Obstet 2005; 88: 31-7.10.1016/j.ijgo.2004.09.008Search in Google Scholar

7. Wikborn C, Pettersson F, Silfverswärd C, Moberg PJ. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int J Gynecol Obstet 1993; 42: 261-4.10.1016/0020-7292(93)90222-ISearch in Google Scholar

8. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systemetis review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 1998; 105: 493-9.10.1111/j.1471-0528.1998.tb10148.xSearch in Google Scholar

9. Takač I, Arko D. Diagnosis and treatment of ovarian cancer. In: Štabuc B, editor. Gynecological cancer/ XVI. Course in memoriam dr. Dušana Reje. Ljubljana: Zveza slovenskih društev proti raku; 2008. p. 41-8.Search in Google Scholar

10. Benedet JL. Progres in gynecologic cancer detection and treatment. Int J Gynecol Obstet 2000; 70: 135-47.10.1016/S0020-7292(00)00232-0Search in Google Scholar

11. Bolton KL, Ganda C, Berchuck A, Pharaoh PDP, Gayther SA. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC). J Intern Med 2012; 271: 366-78.10.1111/j.1365-2796.2011.02509.xSearch in Google Scholar

12. Zweemer RP, Verheijen RHM, Menko FH. Differences between hereditary and sporadic ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999; 82: 151-3.10.1016/S0301-2115(98)00218-8Search in Google Scholar

13. Peker I, Kaya E. Darendeliler-Yaman S. Clinic and radiographical evaluation of non - syndromic hypodontia and hyperdontia in permanent dentition. Med Oral Patol Oral Cir Bucal 2009; 14: 393-7.Search in Google Scholar

14. Silva Meza R. Radiographic assessment of congenitally missing teeth in orthodontic patients. Int J Pediatr Dent 2003; 13: 112-6.10.1046/j.1365-263X.2003.00436.x12605629Search in Google Scholar

15. Pemberton TJ, Das P, Patel PI. Hypodontia: genes and future perspectives. Braz J Oral Sci 2005; 4: 695-706.Search in Google Scholar

16. Mattheeuws N, Dermaut L, Martens G. Has hypodontia increased in Caucasians during the 20th century? A meta-analysis. Eur J Orthod 2004; 26: 99-103.10.1093/ejo/26.1.9914994889Search in Google Scholar

17. Poldner BJ, Van’t Hof MA, Van der Linden FP, Kuijpers Jagtmas AM. A meta-analysis of the prevalence of dental agenesis of permenent teeth. Community Dent Oral Epidemiol 2004; 32: 217-26.10.1111/j.1600-0528.2004.00158.xSearch in Google Scholar

18. Peck L, Peck S, Attia Y. Maxillary canine-first premolar transposition, associated dental anomalies and genetic basis. Angle Orthod 1993; 63: 99-109.Search in Google Scholar

19. Thesleff I. Epithelial-mesenhymal signalling regulating tooth morphogenesis. J Cell Science 2003; 116: 1647-8.10.1242/jcs.00410Search in Google Scholar

20. Mostowska A, Biedziak B, Jagodzinski PP. Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis. J Hum Genet 2006; 51: 262-6.10.1007/s10038-005-0353-6Search in Google Scholar

21. Lammi L, Arte S, Somer M, Järvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 2004; 74: 1043-50.10.1086/386293Search in Google Scholar

22. Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D, et al. Wnt and Hedgehog gene pathway expression in serous ovarian cancer. Int J Gynecol Cancer 2011; 21: 975-80.10.1097/IGC.0b013e31821caa6fSearch in Google Scholar

23. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 2001; 61: 8247-55.Search in Google Scholar

24. Benedet JL. Staging classifications and practice guidelines for gynecologic cancer. Int J Gynecol Obstet 2000; 70: 207-312.10.1016/S0020-7292(00)00300-3Search in Google Scholar

25. Lopes NN, Petrilli AS, Caran Em, França CM, Chilvarquer I, Lederman H. Dental abnormalities in children submitted to antineoplastic therapy. J Dent Child 2006; 73: 210-3.Search in Google Scholar

26. Küchler EC, Lips A, Tannure PN, Ho B, Costa MC, Granjeiro JM, et al. Tooth agenesis association with self-reported family history of cancer. J Dent Res 2013; 92: 149-55.10.1177/0022034512468750Search in Google Scholar

27. Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, et al. Role of ß- Catenin /T- Cell Factor-regulate genes in ovarian endometrioid adenocarcinoma. Am J Pathol 2002; 160: 1229-38.10.1016/S0002-9440(10)62550-3Search in Google Scholar

28. Chalothorn LA, Beeman CS, Ebersole JL, Kluemper GT, Hicks EP, Kryscio RJ, et al. Hypodontia as a risk marker for epithelial ovarian cancer: a casecontroled study. J Am Dent Assoc 2008; 139: 163-9.10.14219/jada.archive.2008.013218245684Search in Google Scholar

29. Fekonja A. Hypodontia prevalence over four decades in Slovenian population. J Esthet Restor Dent 2013; doi: 10.1111/jerd.12076. [Epub ahead of print].10.1111/jerd.1207624341573Search in Google Scholar

30. Lurie G, Wilkens LR, Thompson PJ, Matsuno RK, Carney ME, Goodman MT. Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis. Gynecol Oncol 2010; 119: 278-84.10.1016/j.ygyno.2010.05.028294968220591474Search in Google Scholar

31. But I. DNA ploidy and CA 125 in serous ovarian carcinoma [Doctoral Thesis]. Ljubljana: Faculty of Medicine, University of Ljubljana; 1998. Search in Google Scholar